186 related articles for article (PubMed ID: 8277354)
1. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease.
Almeida IC; Krautz GM; Krettli AU; Travassos LR
J Clin Lab Anal; 1993; 7(6):307-16. PubMed ID: 8277354
[TBL] [Abstract][Full Text] [Related]
2. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
[TBL] [Abstract][Full Text] [Related]
3. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
[TBL] [Abstract][Full Text] [Related]
4. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
5. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
Almeida IC; Milani SR; Gorin PA; Travassos LR
J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
[TBL] [Abstract][Full Text] [Related]
6. Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi.
Golgher DB; Colli W; Souto-Padrón T; Zingales B
Mol Biochem Parasitol; 1993 Aug; 60(2):249-64. PubMed ID: 8232416
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a natural human antibody with anti-galactosyl(alpha 1-2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection.
Avila JL; Rojas M; Velazquez-Avila G
Am J Trop Med Hyg; 1992 Oct; 47(4):413-21. PubMed ID: 1279994
[TBL] [Abstract][Full Text] [Related]
8. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.
Milani SR; Travassos LR
Braz J Med Biol Res; 1988; 21(6):1275-86. PubMed ID: 2471563
[TBL] [Abstract][Full Text] [Related]
9. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
[TBL] [Abstract][Full Text] [Related]
10. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
11. Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment.
Gazzinelli RT; Galvão LM; Cardoso JE; Cançado JR; Krettli AU; Brener Z; Gazzinelli G
J Clin Microbiol; 1988 Sep; 26(9):1795-800. PubMed ID: 3141467
[TBL] [Abstract][Full Text] [Related]
12. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives.
Krettli AU
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():142-51. PubMed ID: 19753469
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).
Malchiodi EL; Chiaramonte MG; Taranto NJ; Zwirner NW; Margni RA
Clin Exp Immunol; 1994 Sep; 97(3):417-23. PubMed ID: 8082296
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
Yokoyama-Yasunaka JK; Piazza RM; Umezawa ES; Stolf AM
J Clin Lab Anal; 1998; 12(2):108-14. PubMed ID: 9524295
[TBL] [Abstract][Full Text] [Related]
15. Lytic antibodies in Trypanosoma cruzi-infected persons with low parasitemia.
Zulantay I; Venegas J; Apt W; Solari A; Sanchez G
Am J Trop Med Hyg; 1998 Jun; 58(6):775-9. PubMed ID: 9660462
[TBL] [Abstract][Full Text] [Related]
16. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies.
Gazzinelli RT; Pereira ME; Romanha A; Gazzinelli G; Brener Z
Parasite Immunol; 1991 Jul; 13(4):345-56. PubMed ID: 1717927
[TBL] [Abstract][Full Text] [Related]
17. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies.
Pereira-Chioccola VL; Acosta-Serrano A; Correia de Almeida I; Ferguson MA; Souto-Padron T; Rodrigues MM; Travassos LR; Schenkman S
J Cell Sci; 2000 Apr; 113 ( Pt 7)():1299-307. PubMed ID: 10704380
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Galα(1,3)Galβ(1,4)GlcNAcα-, Galβ(1,4)GlcNAcα- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease.
Schocker NS; Portillo S; Brito CR; Marques AF; Almeida IC; Michael K
Glycobiology; 2016 Jan; 26(1):39-50. PubMed ID: 26384953
[TBL] [Abstract][Full Text] [Related]
20. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
Wallace A; Sanchez G; Venegas J; Solari A
Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
